Back to company

FORWARD PHARMA A/S: Financial statements 2020

CVR: 28865880

FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -7,763,728 and a net result of DKK -42,201,691 compared with DKK -28,465,258 the year before. Equity amounted to DKK 474,106,683. The solvency ratio was 82.5%. The company had 2 employees in the financial year.

Gross Profit
-7,763,728 kr.
Profit/Loss
-42,201,691 kr.
Equity
474,106,683 kr.
Total Assets
574,865,811 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--7.8 mio.-42.2 mio.474.1 mio.2
2019--6 mio.-28.5 mio.515.9 mio.3
20180-7.6 mio.-54.3 mio.534.6 mio.3
20171.3 mia.-880.2 mio.89.4 mio.-
2016--2 mio.189.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is FORWARD PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

FORWARD PHARMA A/S: The 2019 annual report is outJun 16, 2020

FORWARD PHARMA A/S has published its annual report for 2019. Gross profit came to DKK -5,969,155, and the net result was DKK -28,465,258.

About FORWARD PHARMA A/S

FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.